nodes	percent_of_prediction	percent_of_DWPC	metapath
Bicalutamide—CYP2D6—Ciclesonide—asthma	0.0286	0.0399	CbGbCtD
Bicalutamide—CYP2C19—Zafirlukast—asthma	0.0274	0.0383	CbGbCtD
Bicalutamide—CYP2C19—Arformoterol—asthma	0.0265	0.037	CbGbCtD
Bicalutamide—CYP2C19—Formoterol—asthma	0.0265	0.037	CbGbCtD
Bicalutamide—CYP2C9—Zileuton—asthma	0.0259	0.0362	CbGbCtD
Bicalutamide—CYP2D6—Ipratropium bromide—asthma	0.0237	0.0331	CbGbCtD
Bicalutamide—CYP2C9—Zafirlukast—asthma	0.0228	0.0318	CbGbCtD
Bicalutamide—CYP3A4—Fluticasone furoate—asthma	0.0223	0.0311	CbGbCtD
Bicalutamide—CYP2C9—Arformoterol—asthma	0.022	0.0307	CbGbCtD
Bicalutamide—CYP2C9—Formoterol—asthma	0.022	0.0307	CbGbCtD
Bicalutamide—CYP2D6—Zafirlukast—asthma	0.0208	0.0291	CbGbCtD
Bicalutamide—CYP2D6—Arformoterol—asthma	0.0201	0.0281	CbGbCtD
Bicalutamide—CYP2D6—Formoterol—asthma	0.0201	0.0281	CbGbCtD
Bicalutamide—CYP2C19—Loratadine—asthma	0.0201	0.028	CbGbCtD
Bicalutamide—CYP3A4—Budesonide—asthma	0.0199	0.0277	CbGbCtD
Bicalutamide—CYP3A4—Ciclesonide—asthma	0.0182	0.0254	CbGbCtD
Bicalutamide—CYP3A4—Indacaterol—asthma	0.0182	0.0254	CbGbCtD
Bicalutamide—CYP2D6—Tiotropium—asthma	0.0179	0.0251	CbGbCtD
Bicalutamide—CYP2C9—Theophylline—asthma	0.0176	0.0246	CbGbCtD
Bicalutamide—CYP3A4—Salmeterol—asthma	0.0169	0.0236	CbGbCtD
Bicalutamide—CYP3A4—Flunisolide—asthma	0.0169	0.0236	CbGbCtD
Bicalutamide—CYP3A4—Salbutamol—asthma	0.0169	0.0236	CbGbCtD
Bicalutamide—CYP2C9—Loratadine—asthma	0.0167	0.0233	CbGbCtD
Bicalutamide—CYP2C9—Montelukast—asthma	0.0167	0.0233	CbGbCtD
Bicalutamide—CYP2D6—Theophylline—asthma	0.0161	0.0225	CbGbCtD
Bicalutamide—CYP2D6—Loratadine—asthma	0.0153	0.0213	CbGbCtD
Bicalutamide—CYP3A4—Zileuton—asthma	0.0151	0.021	CbGbCtD
Bicalutamide—CYP3A4—Ipratropium bromide—asthma	0.0151	0.021	CbGbCtD
Bicalutamide—CYP3A4—Fluticasone Propionate—asthma	0.0144	0.0201	CbGbCtD
Bicalutamide—CYP3A4—Zafirlukast—asthma	0.0133	0.0185	CbGbCtD
Bicalutamide—CYP3A4—Tiotropium—asthma	0.0114	0.0159	CbGbCtD
Bicalutamide—CYP2C19—Prednisone—asthma	0.0111	0.0155	CbGbCtD
Bicalutamide—CYP3A4—Aminophylline—asthma	0.0109	0.0152	CbGbCtD
Bicalutamide—CYP3A4—Theophylline—asthma	0.0102	0.0143	CbGbCtD
Bicalutamide—CYP3A4—Loratadine—asthma	0.0097	0.0135	CbGbCtD
Bicalutamide—CYP3A4—Montelukast—asthma	0.0097	0.0135	CbGbCtD
Bicalutamide—CYP3A4—Methylprednisolone—asthma	0.00887	0.0124	CbGbCtD
Bicalutamide—CYP2C19—Dexamethasone—asthma	0.00694	0.00969	CbGbCtD
Bicalutamide—CYP3A4—Triamcinolone—asthma	0.00672	0.00939	CbGbCtD
Bicalutamide—CYP2C9—Dexamethasone—asthma	0.00577	0.00806	CbGbCtD
Bicalutamide—CYP3A4—Betamethasone—asthma	0.00577	0.00806	CbGbCtD
Bicalutamide—CYP3A4—Prednisolone—asthma	0.00569	0.00795	CbGbCtD
Bicalutamide—CYP3A4—Hydrocortisone—asthma	0.00539	0.00754	CbGbCtD
Bicalutamide—CYP3A4—Prednisone—asthma	0.00537	0.00751	CbGbCtD
Bicalutamide—CYP2D6—Dexamethasone—asthma	0.00528	0.00737	CbGbCtD
Bicalutamide—CYP3A4—Dexamethasone—asthma	0.00335	0.00469	CbGbCtD
Bicalutamide—Enzalutamide—ALB—asthma	0.000761	1	CrCbGaD
Bicalutamide—AR—Regulation of nuclear SMAD2/3 signaling—VDR—asthma	9.7e-05	0.00687	CbGpPWpGaD
Bicalutamide—CYP2C9—Arachidonic acid metabolism—ALOX5—asthma	9.54e-05	0.00676	CbGpPWpGaD
Bicalutamide—AR—Regulation of nuclear SMAD2/3 signaling—IL10—asthma	9.44e-05	0.00668	CbGpPWpGaD
Bicalutamide—AR—Regulation of nuclear SMAD2/3 signaling—SMAD3—asthma	9.08e-05	0.00643	CbGpPWpGaD
Bicalutamide—CYP2C19—Melatonin metabolism and effects—EDN1—asthma	9.07e-05	0.00642	CbGpPWpGaD
Bicalutamide—AR—SIDS Susceptibility Pathways—IL13—asthma	8.93e-05	0.00632	CbGpPWpGaD
Bicalutamide—AR—Regulation of nuclear SMAD2/3 signaling—NR3C1—asthma	8.73e-05	0.00618	CbGpPWpGaD
Bicalutamide—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—asthma	8.49e-05	0.00602	CbGpPWpGaD
Bicalutamide—AR—Androgen receptor signaling pathway—SMAD3—asthma	8.42e-05	0.00597	CbGpPWpGaD
Bicalutamide—CYP2D6—Melatonin metabolism and effects—EDN1—asthma	8.34e-05	0.00591	CbGpPWpGaD
Bicalutamide—AR—Notch-mediated HES/HEY network—CD4—asthma	8.28e-05	0.00587	CbGpPWpGaD
Bicalutamide—CYP3A4—Metapathway biotransformation—HNMT—asthma	8.23e-05	0.00583	CbGpPWpGaD
Bicalutamide—AR—SIDS Susceptibility Pathways—TAC1—asthma	8.22e-05	0.00582	CbGpPWpGaD
Bicalutamide—AR—SIDS Susceptibility Pathways—GATA3—asthma	8.06e-05	0.00571	CbGpPWpGaD
Bicalutamide—CYP3A4—Estrogen metabolism—GSTM1—asthma	7.89e-05	0.00559	CbGpPWpGaD
Bicalutamide—AR—Regulation of nuclear SMAD2/3 signaling—CDK2—asthma	7.88e-05	0.00558	CbGpPWpGaD
Bicalutamide—AR—SIDS Susceptibility Pathways—IL1RN—asthma	7.8e-05	0.00553	CbGpPWpGaD
Bicalutamide—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—asthma	7.4e-05	0.00524	CbGpPWpGaD
Bicalutamide—AR—SIDS Susceptibility Pathways—ESR2—asthma	7.23e-05	0.00512	CbGpPWpGaD
Bicalutamide—CYP2C19—Phase 1 - Functionalization of compounds—ALDH2—asthma	6.7e-05	0.00475	CbGpPWpGaD
Bicalutamide—AR—Notch-mediated HES/HEY network—STAT3—asthma	6.41e-05	0.00454	CbGpPWpGaD
Bicalutamide—Syncope—Prednisolone—asthma	6.2e-05	0.00023	CcSEcCtD
Bicalutamide—Dermatitis—Salbutamol—asthma	6.2e-05	0.00023	CcSEcCtD
Bicalutamide—Nausea—Arformoterol—asthma	6.19e-05	0.00023	CcSEcCtD
Bicalutamide—Nausea—Formoterol—asthma	6.19e-05	0.00023	CcSEcCtD
Bicalutamide—Angioedema—Hydrocortisone—asthma	6.17e-05	0.000229	CcSEcCtD
Bicalutamide—CYP2D6—Phase 1 - Functionalization of compounds—ALDH2—asthma	6.17e-05	0.00437	CbGpPWpGaD
Bicalutamide—Headache—Salbutamol—asthma	6.17e-05	0.000229	CcSEcCtD
Bicalutamide—AR—Integrated Pancreatic Cancer Pathway—ESR2—asthma	6.15e-05	0.00436	CbGpPWpGaD
Bicalutamide—Back pain—Triamcinolone—asthma	6.15e-05	0.000228	CcSEcCtD
Bicalutamide—CYP3A4—Tryptophan metabolism—ALDH2—asthma	6.15e-05	0.00436	CbGpPWpGaD
Bicalutamide—CYP2C9—Phase 1 - Functionalization of compounds—ALDH2—asthma	6.11e-05	0.00433	CbGpPWpGaD
Bicalutamide—AR—Regulation of nuclear SMAD2/3 signaling—SERPINE1—asthma	6.09e-05	0.00431	CbGpPWpGaD
Bicalutamide—Loss of consciousness—Prednisolone—asthma	6.08e-05	0.000226	CcSEcCtD
Bicalutamide—Nausea—Montelukast—asthma	6.06e-05	0.000225	CcSEcCtD
Bicalutamide—Vomiting—Budesonide—asthma	6.06e-05	0.000225	CcSEcCtD
Bicalutamide—Syncope—Hydrocortisone—asthma	6.06e-05	0.000225	CcSEcCtD
Bicalutamide—AR—Integrated Pancreatic Cancer Pathway—IL3—asthma	6.04e-05	0.00428	CbGpPWpGaD
Bicalutamide—Angiopathy—Dexamethasone—asthma	6.01e-05	0.000223	CcSEcCtD
Bicalutamide—Angiopathy—Betamethasone—asthma	6.01e-05	0.000223	CcSEcCtD
Bicalutamide—Rash—Budesonide—asthma	6.01e-05	0.000223	CcSEcCtD
Bicalutamide—Dermatitis—Budesonide—asthma	6e-05	0.000223	CcSEcCtD
Bicalutamide—Headache—Budesonide—asthma	5.97e-05	0.000222	CcSEcCtD
Bicalutamide—Hypertension—Prednisolone—asthma	5.97e-05	0.000222	CcSEcCtD
Bicalutamide—Loss of consciousness—Hydrocortisone—asthma	5.94e-05	0.00022	CcSEcCtD
Bicalutamide—Arrhythmia—Betamethasone—asthma	5.92e-05	0.00022	CcSEcCtD
Bicalutamide—Arrhythmia—Dexamethasone—asthma	5.92e-05	0.00022	CcSEcCtD
Bicalutamide—Bradycardia—Prednisone—asthma	5.88e-05	0.000218	CcSEcCtD
Bicalutamide—Alopecia—Betamethasone—asthma	5.86e-05	0.000218	CcSEcCtD
Bicalutamide—Alopecia—Dexamethasone—asthma	5.86e-05	0.000218	CcSEcCtD
Bicalutamide—AR—SIDS Susceptibility Pathways—BDNF—asthma	5.85e-05	0.00414	CbGpPWpGaD
Bicalutamide—Nausea—Salbutamol—asthma	5.85e-05	0.000217	CcSEcCtD
Bicalutamide—Hypertension—Hydrocortisone—asthma	5.83e-05	0.000217	CcSEcCtD
Bicalutamide—Angioedema—Triamcinolone—asthma	5.81e-05	0.000216	CcSEcCtD
Bicalutamide—Haemoglobin—Prednisone—asthma	5.8e-05	0.000215	CcSEcCtD
Bicalutamide—Angioedema—Methylprednisolone—asthma	5.8e-05	0.000215	CcSEcCtD
Bicalutamide—CYP2C19—Arachidonic acid metabolism—PLA2G4A—asthma	5.8e-05	0.00411	CbGpPWpGaD
Bicalutamide—Haemorrhage—Prednisone—asthma	5.77e-05	0.000214	CcSEcCtD
Bicalutamide—Myalgia—Hydrocortisone—asthma	5.75e-05	0.000214	CcSEcCtD
Bicalutamide—Anxiety—Hydrocortisone—asthma	5.73e-05	0.000213	CcSEcCtD
Bicalutamide—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—asthma	5.71e-05	0.000212	CcSEcCtD
Bicalutamide—Syncope—Triamcinolone—asthma	5.7e-05	0.000212	CcSEcCtD
Bicalutamide—Syncope—Methylprednisolone—asthma	5.69e-05	0.000211	CcSEcCtD
Bicalutamide—Nausea—Budesonide—asthma	5.66e-05	0.00021	CcSEcCtD
Bicalutamide—Oedema—Prednisolone—asthma	5.64e-05	0.00021	CcSEcCtD
Bicalutamide—Loss of consciousness—Triamcinolone—asthma	5.59e-05	0.000208	CcSEcCtD
Bicalutamide—AR—SIDS Susceptibility Pathways—IL10—asthma	5.59e-05	0.00396	CbGpPWpGaD
Bicalutamide—Loss of consciousness—Methylprednisolone—asthma	5.58e-05	0.000207	CcSEcCtD
Bicalutamide—Shock—Prednisolone—asthma	5.55e-05	0.000206	CcSEcCtD
Bicalutamide—Cough—Triamcinolone—asthma	5.55e-05	0.000206	CcSEcCtD
Bicalutamide—Oedema—Hydrocortisone—asthma	5.51e-05	0.000205	CcSEcCtD
Bicalutamide—Hypertension—Triamcinolone—asthma	5.49e-05	0.000204	CcSEcCtD
Bicalutamide—Hypertension—Methylprednisolone—asthma	5.48e-05	0.000203	CcSEcCtD
Bicalutamide—Infection—Hydrocortisone—asthma	5.48e-05	0.000203	CcSEcCtD
Bicalutamide—Hyperhidrosis—Prednisolone—asthma	5.46e-05	0.000203	CcSEcCtD
Bicalutamide—AR—Androgen receptor signaling pathway—RHOA—asthma	5.45e-05	0.00386	CbGpPWpGaD
Bicalutamide—AR—Integrated Pancreatic Cancer Pathway—NTRK1—asthma	5.44e-05	0.00385	CbGpPWpGaD
Bicalutamide—Shock—Hydrocortisone—asthma	5.42e-05	0.000201	CcSEcCtD
Bicalutamide—Myalgia—Triamcinolone—asthma	5.41e-05	0.000201	CcSEcCtD
Bicalutamide—Nervous system disorder—Hydrocortisone—asthma	5.41e-05	0.000201	CcSEcCtD
Bicalutamide—Myalgia—Methylprednisolone—asthma	5.4e-05	0.000201	CcSEcCtD
Bicalutamide—Anxiety—Methylprednisolone—asthma	5.38e-05	0.0002	CcSEcCtD
Bicalutamide—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—asthma	5.37e-05	0.000199	CcSEcCtD
Bicalutamide—Skin disorder—Hydrocortisone—asthma	5.35e-05	0.000199	CcSEcCtD
Bicalutamide—Hyperhidrosis—Hydrocortisone—asthma	5.33e-05	0.000198	CcSEcCtD
Bicalutamide—Dry mouth—Triamcinolone—asthma	5.3e-05	0.000197	CcSEcCtD
Bicalutamide—CYP2C9—Arachidonic acid metabolism—PLA2G4A—asthma	5.29e-05	0.00374	CbGpPWpGaD
Bicalutamide—Angioedema—Betamethasone—asthma	5.27e-05	0.000196	CcSEcCtD
Bicalutamide—Angioedema—Dexamethasone—asthma	5.27e-05	0.000196	CcSEcCtD
Bicalutamide—Anorexia—Hydrocortisone—asthma	5.25e-05	0.000195	CcSEcCtD
Bicalutamide—Angiopathy—Prednisone—asthma	5.24e-05	0.000195	CcSEcCtD
Bicalutamide—Confusional state—Methylprednisolone—asthma	5.22e-05	0.000194	CcSEcCtD
Bicalutamide—Immune system disorder—Prednisone—asthma	5.21e-05	0.000194	CcSEcCtD
Bicalutamide—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CXCL8—asthma	5.21e-05	0.00369	CbGpPWpGaD
Bicalutamide—Oedema—Triamcinolone—asthma	5.19e-05	0.000193	CcSEcCtD
Bicalutamide—Syncope—Betamethasone—asthma	5.18e-05	0.000192	CcSEcCtD
Bicalutamide—Syncope—Dexamethasone—asthma	5.18e-05	0.000192	CcSEcCtD
Bicalutamide—AR—SIDS Susceptibility Pathways—NR3C1—asthma	5.17e-05	0.00366	CbGpPWpGaD
Bicalutamide—Arrhythmia—Prednisone—asthma	5.16e-05	0.000192	CcSEcCtD
Bicalutamide—Infection—Triamcinolone—asthma	5.16e-05	0.000191	CcSEcCtD
Bicalutamide—Infection—Methylprednisolone—asthma	5.15e-05	0.000191	CcSEcCtD
Bicalutamide—Shock—Triamcinolone—asthma	5.11e-05	0.00019	CcSEcCtD
Bicalutamide—Insomnia—Prednisolone—asthma	5.11e-05	0.00019	CcSEcCtD
Bicalutamide—Alopecia—Prednisone—asthma	5.1e-05	0.000189	CcSEcCtD
Bicalutamide—Shock—Methylprednisolone—asthma	5.1e-05	0.000189	CcSEcCtD
Bicalutamide—Nervous system disorder—Methylprednisolone—asthma	5.08e-05	0.000189	CcSEcCtD
Bicalutamide—Loss of consciousness—Dexamethasone—asthma	5.07e-05	0.000188	CcSEcCtD
Bicalutamide—Loss of consciousness—Betamethasone—asthma	5.07e-05	0.000188	CcSEcCtD
Bicalutamide—Paraesthesia—Prednisolone—asthma	5.07e-05	0.000188	CcSEcCtD
Bicalutamide—Mental disorder—Prednisone—asthma	5.06e-05	0.000188	CcSEcCtD
Bicalutamide—Skin disorder—Methylprednisolone—asthma	5.03e-05	0.000187	CcSEcCtD
Bicalutamide—Malnutrition—Prednisone—asthma	5.03e-05	0.000187	CcSEcCtD
Bicalutamide—Musculoskeletal discomfort—Hydrocortisone—asthma	5.02e-05	0.000187	CcSEcCtD
Bicalutamide—Hyperhidrosis—Triamcinolone—asthma	5.02e-05	0.000186	CcSEcCtD
Bicalutamide—Hyperhidrosis—Methylprednisolone—asthma	5.01e-05	0.000186	CcSEcCtD
Bicalutamide—Insomnia—Hydrocortisone—asthma	4.99e-05	0.000185	CcSEcCtD
Bicalutamide—Hypertension—Betamethasone—asthma	4.98e-05	0.000185	CcSEcCtD
Bicalutamide—Hypertension—Dexamethasone—asthma	4.98e-05	0.000185	CcSEcCtD
Bicalutamide—AR—Integrated Pancreatic Cancer Pathway—BDNF—asthma	4.98e-05	0.00352	CbGpPWpGaD
Bicalutamide—Paraesthesia—Hydrocortisone—asthma	4.95e-05	0.000184	CcSEcCtD
Bicalutamide—Myalgia—Betamethasone—asthma	4.91e-05	0.000182	CcSEcCtD
Bicalutamide—Myalgia—Dexamethasone—asthma	4.91e-05	0.000182	CcSEcCtD
Bicalutamide—Anxiety—Dexamethasone—asthma	4.9e-05	0.000182	CcSEcCtD
Bicalutamide—Anxiety—Betamethasone—asthma	4.9e-05	0.000182	CcSEcCtD
Bicalutamide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—asthma	4.88e-05	0.00346	CbGpPWpGaD
Bicalutamide—Dyspepsia—Hydrocortisone—asthma	4.85e-05	0.00018	CcSEcCtD
Bicalutamide—Pain—Prednisolone—asthma	4.83e-05	0.000179	CcSEcCtD
Bicalutamide—Decreased appetite—Hydrocortisone—asthma	4.79e-05	0.000178	CcSEcCtD
Bicalutamide—AR—Integrated Breast Cancer Pathway—CDK2—asthma	4.79e-05	0.00339	CbGpPWpGaD
Bicalutamide—Gastrointestinal disorder—Hydrocortisone—asthma	4.76e-05	0.000177	CcSEcCtD
Bicalutamide—Fatigue—Hydrocortisone—asthma	4.75e-05	0.000176	CcSEcCtD
Bicalutamide—AR—Integrated Pancreatic Cancer Pathway—PLA2G4A—asthma	4.75e-05	0.00336	CbGpPWpGaD
Bicalutamide—Musculoskeletal discomfort—Triamcinolone—asthma	4.73e-05	0.000176	CcSEcCtD
Bicalutamide—Musculoskeletal discomfort—Methylprednisolone—asthma	4.72e-05	0.000175	CcSEcCtD
Bicalutamide—Pain—Hydrocortisone—asthma	4.71e-05	0.000175	CcSEcCtD
Bicalutamide—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MMP9—asthma	4.71e-05	0.00334	CbGpPWpGaD
Bicalutamide—Oedema—Dexamethasone—asthma	4.71e-05	0.000175	CcSEcCtD
Bicalutamide—Oedema—Betamethasone—asthma	4.71e-05	0.000175	CcSEcCtD
Bicalutamide—Insomnia—Triamcinolone—asthma	4.69e-05	0.000174	CcSEcCtD
Bicalutamide—Insomnia—Methylprednisolone—asthma	4.68e-05	0.000174	CcSEcCtD
Bicalutamide—Infection—Betamethasone—asthma	4.68e-05	0.000174	CcSEcCtD
Bicalutamide—Infection—Dexamethasone—asthma	4.68e-05	0.000174	CcSEcCtD
Bicalutamide—Paraesthesia—Triamcinolone—asthma	4.66e-05	0.000173	CcSEcCtD
Bicalutamide—Feeling abnormal—Prednisolone—asthma	4.65e-05	0.000173	CcSEcCtD
Bicalutamide—Paraesthesia—Methylprednisolone—asthma	4.65e-05	0.000173	CcSEcCtD
Bicalutamide—Anaemia—Prednisone—asthma	4.65e-05	0.000172	CcSEcCtD
Bicalutamide—Shock—Betamethasone—asthma	4.63e-05	0.000172	CcSEcCtD
Bicalutamide—Shock—Dexamethasone—asthma	4.63e-05	0.000172	CcSEcCtD
Bicalutamide—Dyspnoea—Triamcinolone—asthma	4.63e-05	0.000172	CcSEcCtD
Bicalutamide—Nervous system disorder—Dexamethasone—asthma	4.62e-05	0.000172	CcSEcCtD
Bicalutamide—Nervous system disorder—Betamethasone—asthma	4.62e-05	0.000172	CcSEcCtD
Bicalutamide—Thrombocytopenia—Dexamethasone—asthma	4.61e-05	0.000171	CcSEcCtD
Bicalutamide—Thrombocytopenia—Betamethasone—asthma	4.61e-05	0.000171	CcSEcCtD
Bicalutamide—Angioedema—Prednisone—asthma	4.59e-05	0.000171	CcSEcCtD
Bicalutamide—Dyspepsia—Triamcinolone—asthma	4.57e-05	0.00017	CcSEcCtD
Bicalutamide—Dyspepsia—Methylprednisolone—asthma	4.56e-05	0.000169	CcSEcCtD
Bicalutamide—Hyperhidrosis—Dexamethasone—asthma	4.55e-05	0.000169	CcSEcCtD
Bicalutamide—Hyperhidrosis—Betamethasone—asthma	4.55e-05	0.000169	CcSEcCtD
Bicalutamide—Feeling abnormal—Hydrocortisone—asthma	4.54e-05	0.000169	CcSEcCtD
Bicalutamide—Gastrointestinal pain—Hydrocortisone—asthma	4.51e-05	0.000167	CcSEcCtD
Bicalutamide—Syncope—Prednisone—asthma	4.51e-05	0.000167	CcSEcCtD
Bicalutamide—Anorexia—Dexamethasone—asthma	4.49e-05	0.000167	CcSEcCtD
Bicalutamide—Anorexia—Betamethasone—asthma	4.49e-05	0.000167	CcSEcCtD
Bicalutamide—Urticaria—Prednisolone—asthma	4.48e-05	0.000167	CcSEcCtD
Bicalutamide—Fatigue—Triamcinolone—asthma	4.48e-05	0.000166	CcSEcCtD
Bicalutamide—Fatigue—Methylprednisolone—asthma	4.47e-05	0.000166	CcSEcCtD
Bicalutamide—Pain—Triamcinolone—asthma	4.44e-05	0.000165	CcSEcCtD
Bicalutamide—Loss of consciousness—Prednisone—asthma	4.42e-05	0.000164	CcSEcCtD
Bicalutamide—Urticaria—Hydrocortisone—asthma	4.38e-05	0.000163	CcSEcCtD
Bicalutamide—Abdominal pain—Hydrocortisone—asthma	4.36e-05	0.000162	CcSEcCtD
Bicalutamide—Body temperature increased—Hydrocortisone—asthma	4.36e-05	0.000162	CcSEcCtD
Bicalutamide—Hypertension—Prednisone—asthma	4.34e-05	0.000161	CcSEcCtD
Bicalutamide—AR—Androgen receptor signaling pathway—PTEN—asthma	4.3e-05	0.00305	CbGpPWpGaD
Bicalutamide—Musculoskeletal discomfort—Dexamethasone—asthma	4.29e-05	0.000159	CcSEcCtD
Bicalutamide—Musculoskeletal discomfort—Betamethasone—asthma	4.29e-05	0.000159	CcSEcCtD
Bicalutamide—Myalgia—Prednisone—asthma	4.28e-05	0.000159	CcSEcCtD
Bicalutamide—Feeling abnormal—Triamcinolone—asthma	4.28e-05	0.000159	CcSEcCtD
Bicalutamide—Feeling abnormal—Methylprednisolone—asthma	4.27e-05	0.000158	CcSEcCtD
Bicalutamide—Anxiety—Prednisone—asthma	4.26e-05	0.000158	CcSEcCtD
Bicalutamide—Insomnia—Dexamethasone—asthma	4.26e-05	0.000158	CcSEcCtD
Bicalutamide—Insomnia—Betamethasone—asthma	4.26e-05	0.000158	CcSEcCtD
Bicalutamide—Unspecified disorder of skin and subcutaneous tissue—Prednisone—asthma	4.25e-05	0.000158	CcSEcCtD
Bicalutamide—Gastrointestinal pain—Methylprednisolone—asthma	4.24e-05	0.000157	CcSEcCtD
Bicalutamide—Paraesthesia—Dexamethasone—asthma	4.23e-05	0.000157	CcSEcCtD
Bicalutamide—Paraesthesia—Betamethasone—asthma	4.23e-05	0.000157	CcSEcCtD
Bicalutamide—Hypersensitivity—Prednisolone—asthma	4.16e-05	0.000154	CcSEcCtD
Bicalutamide—Dyspepsia—Betamethasone—asthma	4.15e-05	0.000154	CcSEcCtD
Bicalutamide—Dyspepsia—Dexamethasone—asthma	4.15e-05	0.000154	CcSEcCtD
Bicalutamide—Urticaria—Triamcinolone—asthma	4.12e-05	0.000153	CcSEcCtD
Bicalutamide—Urticaria—Methylprednisolone—asthma	4.11e-05	0.000153	CcSEcCtD
Bicalutamide—Body temperature increased—Triamcinolone—asthma	4.1e-05	0.000152	CcSEcCtD
Bicalutamide—Oedema—Prednisone—asthma	4.1e-05	0.000152	CcSEcCtD
Bicalutamide—Abdominal pain—Methylprednisolone—asthma	4.09e-05	0.000152	CcSEcCtD
Bicalutamide—Decreased appetite—Betamethasone—asthma	4.09e-05	0.000152	CcSEcCtD
Bicalutamide—Decreased appetite—Dexamethasone—asthma	4.09e-05	0.000152	CcSEcCtD
Bicalutamide—Infection—Prednisone—asthma	4.07e-05	0.000151	CcSEcCtD
Bicalutamide—Gastrointestinal disorder—Dexamethasone—asthma	4.07e-05	0.000151	CcSEcCtD
Bicalutamide—Gastrointestinal disorder—Betamethasone—asthma	4.07e-05	0.000151	CcSEcCtD
Bicalutamide—AR—Generic Transcription Pathway—CARM1—asthma	4.06e-05	0.00288	CbGpPWpGaD
Bicalutamide—Hypersensitivity—Hydrocortisone—asthma	4.06e-05	0.000151	CcSEcCtD
Bicalutamide—Fatigue—Betamethasone—asthma	4.06e-05	0.000151	CcSEcCtD
Bicalutamide—Fatigue—Dexamethasone—asthma	4.06e-05	0.000151	CcSEcCtD
Bicalutamide—Shock—Prednisone—asthma	4.04e-05	0.00015	CcSEcCtD
Bicalutamide—CYP3A4—Phase 1 - Functionalization of compounds—ALDH2—asthma	4.03e-05	0.00285	CbGpPWpGaD
Bicalutamide—Pain—Betamethasone—asthma	4.03e-05	0.00015	CcSEcCtD
Bicalutamide—Pain—Dexamethasone—asthma	4.03e-05	0.00015	CcSEcCtD
Bicalutamide—Nervous system disorder—Prednisone—asthma	4.02e-05	0.000149	CcSEcCtD
Bicalutamide—AR—Gene Expression—PRMT5—asthma	4.01e-05	0.00284	CbGpPWpGaD
Bicalutamide—Skin disorder—Prednisone—asthma	3.98e-05	0.000148	CcSEcCtD
Bicalutamide—Hyperhidrosis—Prednisone—asthma	3.97e-05	0.000147	CcSEcCtD
Bicalutamide—AR—Integrated Pancreatic Cancer Pathway—CDK2—asthma	3.97e-05	0.00281	CbGpPWpGaD
Bicalutamide—Asthenia—Hydrocortisone—asthma	3.96e-05	0.000147	CcSEcCtD
Bicalutamide—CYP3A4—Tryptophan metabolism—CAT—asthma	3.95e-05	0.00279	CbGpPWpGaD
Bicalutamide—Anorexia—Prednisone—asthma	3.91e-05	0.000145	CcSEcCtD
Bicalutamide—Pruritus—Hydrocortisone—asthma	3.9e-05	0.000145	CcSEcCtD
Bicalutamide—Feeling abnormal—Dexamethasone—asthma	3.88e-05	0.000144	CcSEcCtD
Bicalutamide—Feeling abnormal—Betamethasone—asthma	3.88e-05	0.000144	CcSEcCtD
Bicalutamide—AR—SIDS Susceptibility Pathways—IL6R—asthma	3.85e-05	0.00273	CbGpPWpGaD
Bicalutamide—Gastrointestinal pain—Dexamethasone—asthma	3.85e-05	0.000143	CcSEcCtD
Bicalutamide—Gastrointestinal pain—Betamethasone—asthma	3.85e-05	0.000143	CcSEcCtD
Bicalutamide—AR—Androgen receptor signaling pathway—STAT3—asthma	3.85e-05	0.00273	CbGpPWpGaD
Bicalutamide—Hypersensitivity—Triamcinolone—asthma	3.82e-05	0.000142	CcSEcCtD
Bicalutamide—Hypersensitivity—Methylprednisolone—asthma	3.82e-05	0.000142	CcSEcCtD
Bicalutamide—Diarrhoea—Hydrocortisone—asthma	3.77e-05	0.00014	CcSEcCtD
Bicalutamide—Urticaria—Betamethasone—asthma	3.74e-05	0.000139	CcSEcCtD
Bicalutamide—Urticaria—Dexamethasone—asthma	3.74e-05	0.000139	CcSEcCtD
Bicalutamide—Musculoskeletal discomfort—Prednisone—asthma	3.74e-05	0.000139	CcSEcCtD
Bicalutamide—Dizziness—Prednisolone—asthma	3.73e-05	0.000139	CcSEcCtD
Bicalutamide—Asthenia—Triamcinolone—asthma	3.72e-05	0.000138	CcSEcCtD
Bicalutamide—Abdominal pain—Betamethasone—asthma	3.72e-05	0.000138	CcSEcCtD
Bicalutamide—Abdominal pain—Dexamethasone—asthma	3.72e-05	0.000138	CcSEcCtD
Bicalutamide—Body temperature increased—Betamethasone—asthma	3.72e-05	0.000138	CcSEcCtD
Bicalutamide—Body temperature increased—Dexamethasone—asthma	3.72e-05	0.000138	CcSEcCtD
Bicalutamide—Asthenia—Methylprednisolone—asthma	3.72e-05	0.000138	CcSEcCtD
Bicalutamide—Insomnia—Prednisone—asthma	3.71e-05	0.000138	CcSEcCtD
Bicalutamide—Paraesthesia—Prednisone—asthma	3.68e-05	0.000137	CcSEcCtD
Bicalutamide—Pruritus—Triamcinolone—asthma	3.67e-05	0.000136	CcSEcCtD
Bicalutamide—Pruritus—Methylprednisolone—asthma	3.66e-05	0.000136	CcSEcCtD
Bicalutamide—Dizziness—Hydrocortisone—asthma	3.65e-05	0.000135	CcSEcCtD
Bicalutamide—Dyspepsia—Prednisone—asthma	3.61e-05	0.000134	CcSEcCtD
Bicalutamide—Decreased appetite—Prednisone—asthma	3.57e-05	0.000132	CcSEcCtD
Bicalutamide—CYP2C19—Biological oxidations—ALDH2—asthma	3.56e-05	0.00252	CbGpPWpGaD
Bicalutamide—Rash—Prednisolone—asthma	3.56e-05	0.000132	CcSEcCtD
Bicalutamide—Dermatitis—Prednisolone—asthma	3.56e-05	0.000132	CcSEcCtD
Bicalutamide—Diarrhoea—Methylprednisolone—asthma	3.54e-05	0.000132	CcSEcCtD
Bicalutamide—CYP2C19—Cytochrome P450 - arranged by substrate type—POMC—asthma	3.54e-05	0.00251	CbGpPWpGaD
Bicalutamide—Fatigue—Prednisone—asthma	3.54e-05	0.000131	CcSEcCtD
Bicalutamide—Headache—Prednisolone—asthma	3.54e-05	0.000131	CcSEcCtD
Bicalutamide—Constipation—Prednisone—asthma	3.51e-05	0.00013	CcSEcCtD
Bicalutamide—Vomiting—Hydrocortisone—asthma	3.5e-05	0.00013	CcSEcCtD
Bicalutamide—AR—Androgen receptor signaling pathway—EGFR—asthma	3.5e-05	0.00248	CbGpPWpGaD
Bicalutamide—Rash—Hydrocortisone—asthma	3.48e-05	0.000129	CcSEcCtD
Bicalutamide—Dermatitis—Hydrocortisone—asthma	3.47e-05	0.000129	CcSEcCtD
Bicalutamide—Headache—Hydrocortisone—asthma	3.45e-05	0.000128	CcSEcCtD
Bicalutamide—Dizziness—Triamcinolone—asthma	3.43e-05	0.000127	CcSEcCtD
Bicalutamide—Dizziness—Methylprednisolone—asthma	3.42e-05	0.000127	CcSEcCtD
Bicalutamide—AR—Integrated Breast Cancer Pathway—BCL2—asthma	3.4e-05	0.00241	CbGpPWpGaD
Bicalutamide—CYP2C19—Biological oxidations—GSTT1—asthma	3.39e-05	0.0024	CbGpPWpGaD
Bicalutamide—Feeling abnormal—Prednisone—asthma	3.38e-05	0.000126	CcSEcCtD
Bicalutamide—Asthenia—Dexamethasone—asthma	3.38e-05	0.000125	CcSEcCtD
Bicalutamide—Asthenia—Betamethasone—asthma	3.38e-05	0.000125	CcSEcCtD
Bicalutamide—Gastrointestinal pain—Prednisone—asthma	3.35e-05	0.000125	CcSEcCtD
Bicalutamide—Nausea—Prednisolone—asthma	3.35e-05	0.000125	CcSEcCtD
Bicalutamide—Pruritus—Betamethasone—asthma	3.33e-05	0.000124	CcSEcCtD
Bicalutamide—Pruritus—Dexamethasone—asthma	3.33e-05	0.000124	CcSEcCtD
Bicalutamide—Vomiting—Triamcinolone—asthma	3.3e-05	0.000123	CcSEcCtD
Bicalutamide—Vomiting—Methylprednisolone—asthma	3.29e-05	0.000122	CcSEcCtD
Bicalutamide—CYP2D6—Biological oxidations—ALDH2—asthma	3.28e-05	0.00232	CbGpPWpGaD
Bicalutamide—Nausea—Hydrocortisone—asthma	3.27e-05	0.000122	CcSEcCtD
Bicalutamide—Rash—Triamcinolone—asthma	3.27e-05	0.000122	CcSEcCtD
Bicalutamide—Dermatitis—Triamcinolone—asthma	3.27e-05	0.000121	CcSEcCtD
Bicalutamide—CYP2C19—Arachidonic acid metabolism—PTGS2—asthma	3.27e-05	0.00231	CbGpPWpGaD
Bicalutamide—Rash—Methylprednisolone—asthma	3.27e-05	0.000121	CcSEcCtD
Bicalutamide—Dermatitis—Methylprednisolone—asthma	3.26e-05	0.000121	CcSEcCtD
Bicalutamide—Urticaria—Prednisone—asthma	3.26e-05	0.000121	CcSEcCtD
Bicalutamide—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—asthma	3.26e-05	0.00231	CbGpPWpGaD
Bicalutamide—Headache—Triamcinolone—asthma	3.25e-05	0.000121	CcSEcCtD
Bicalutamide—CYP2C9—Biological oxidations—ALDH2—asthma	3.25e-05	0.0023	CbGpPWpGaD
Bicalutamide—Headache—Methylprednisolone—asthma	3.24e-05	0.00012	CcSEcCtD
Bicalutamide—Body temperature increased—Prednisone—asthma	3.24e-05	0.00012	CcSEcCtD
Bicalutamide—Abdominal pain—Prednisone—asthma	3.24e-05	0.00012	CcSEcCtD
Bicalutamide—CYP2C19—Metabolism of lipids and lipoproteins—LTC4S—asthma	3.23e-05	0.00229	CbGpPWpGaD
Bicalutamide—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—asthma	3.23e-05	0.00229	CbGpPWpGaD
Bicalutamide—AR—Generic Transcription Pathway—PARP1—asthma	3.23e-05	0.00229	CbGpPWpGaD
Bicalutamide—Diarrhoea—Betamethasone—asthma	3.22e-05	0.00012	CcSEcCtD
Bicalutamide—Diarrhoea—Dexamethasone—asthma	3.22e-05	0.00012	CcSEcCtD
Bicalutamide—CYP2D6—Biological oxidations—GSTT1—asthma	3.12e-05	0.00221	CbGpPWpGaD
Bicalutamide—Dizziness—Dexamethasone—asthma	3.11e-05	0.000116	CcSEcCtD
Bicalutamide—Dizziness—Betamethasone—asthma	3.11e-05	0.000116	CcSEcCtD
Bicalutamide—CYP2C9—Biological oxidations—GSTT1—asthma	3.09e-05	0.00219	CbGpPWpGaD
Bicalutamide—Nausea—Triamcinolone—asthma	3.08e-05	0.000114	CcSEcCtD
Bicalutamide—Nausea—Methylprednisolone—asthma	3.08e-05	0.000114	CcSEcCtD
Bicalutamide—AR—Generic Transcription Pathway—ESR2—asthma	3.06e-05	0.00216	CbGpPWpGaD
Bicalutamide—AR—SIDS Susceptibility Pathways—CXCL8—asthma	3.05e-05	0.00216	CbGpPWpGaD
Bicalutamide—Hypersensitivity—Prednisone—asthma	3.02e-05	0.000112	CcSEcCtD
Bicalutamide—Vomiting—Dexamethasone—asthma	2.99e-05	0.000111	CcSEcCtD
Bicalutamide—Vomiting—Betamethasone—asthma	2.99e-05	0.000111	CcSEcCtD
Bicalutamide—CYP2C9—Arachidonic acid metabolism—PTGS2—asthma	2.98e-05	0.00211	CbGpPWpGaD
Bicalutamide—Rash—Betamethasone—asthma	2.97e-05	0.00011	CcSEcCtD
Bicalutamide—Rash—Dexamethasone—asthma	2.97e-05	0.00011	CcSEcCtD
Bicalutamide—Dermatitis—Dexamethasone—asthma	2.97e-05	0.00011	CcSEcCtD
Bicalutamide—Dermatitis—Betamethasone—asthma	2.97e-05	0.00011	CcSEcCtD
Bicalutamide—Headache—Dexamethasone—asthma	2.95e-05	0.00011	CcSEcCtD
Bicalutamide—Headache—Betamethasone—asthma	2.95e-05	0.00011	CcSEcCtD
Bicalutamide—CYP2C9—Metabolism of lipids and lipoproteins—LTC4S—asthma	2.94e-05	0.00209	CbGpPWpGaD
Bicalutamide—Asthenia—Prednisone—asthma	2.94e-05	0.000109	CcSEcCtD
Bicalutamide—AR—SIDS Susceptibility Pathways—IL1B—asthma	2.93e-05	0.00208	CbGpPWpGaD
Bicalutamide—Pruritus—Prednisone—asthma	2.9e-05	0.000108	CcSEcCtD
Bicalutamide—CYP2C19—Phase 1 - Functionalization of compounds—POMC—asthma	2.87e-05	0.00203	CbGpPWpGaD
Bicalutamide—AR—Integrated Pancreatic Cancer Pathway—BCL2—asthma	2.82e-05	0.002	CbGpPWpGaD
Bicalutamide—AR—Integrated Breast Cancer Pathway—PTEN—asthma	2.82e-05	0.002	CbGpPWpGaD
Bicalutamide—Diarrhoea—Prednisone—asthma	2.81e-05	0.000104	CcSEcCtD
Bicalutamide—CYP2C19—Metabolism of lipids and lipoproteins—LTA4H—asthma	2.8e-05	0.00198	CbGpPWpGaD
Bicalutamide—Nausea—Betamethasone—asthma	2.8e-05	0.000104	CcSEcCtD
Bicalutamide—Nausea—Dexamethasone—asthma	2.8e-05	0.000104	CcSEcCtD
Bicalutamide—Dizziness—Prednisone—asthma	2.71e-05	0.000101	CcSEcCtD
Bicalutamide—AR—Integrated Pancreatic Cancer Pathway—PTGS2—asthma	2.68e-05	0.0019	CbGpPWpGaD
Bicalutamide—CYP2D6—Phase 1 - Functionalization of compounds—POMC—asthma	2.64e-05	0.00187	CbGpPWpGaD
Bicalutamide—CYP2C9—Phase 1 - Functionalization of compounds—POMC—asthma	2.62e-05	0.00185	CbGpPWpGaD
Bicalutamide—Vomiting—Prednisone—asthma	2.61e-05	9.68e-05	CcSEcCtD
Bicalutamide—Rash—Prednisone—asthma	2.59e-05	9.6e-05	CcSEcCtD
Bicalutamide—Dermatitis—Prednisone—asthma	2.58e-05	9.59e-05	CcSEcCtD
Bicalutamide—Headache—Prednisone—asthma	2.57e-05	9.54e-05	CcSEcCtD
Bicalutamide—CYP2C9—Metabolism of lipids and lipoproteins—LTA4H—asthma	2.55e-05	0.00181	CbGpPWpGaD
Bicalutamide—AR—Integrated Breast Cancer Pathway—VEGFA—asthma	2.55e-05	0.0018	CbGpPWpGaD
Bicalutamide—AR—SIDS Susceptibility Pathways—VEGFA—asthma	2.48e-05	0.00176	CbGpPWpGaD
Bicalutamide—Nausea—Prednisone—asthma	2.44e-05	9.05e-05	CcSEcCtD
Bicalutamide—AR—Generic Transcription Pathway—VDR—asthma	2.43e-05	0.00172	CbGpPWpGaD
Bicalutamide—CYP2C19—Biological oxidations—GSTP1—asthma	2.35e-05	0.00166	CbGpPWpGaD
Bicalutamide—AR—Integrated Pancreatic Cancer Pathway—PTEN—asthma	2.34e-05	0.00165	CbGpPWpGaD
Bicalutamide—CYP2C19—Metapathway biotransformation—GSTP1—asthma	2.32e-05	0.00164	CbGpPWpGaD
Bicalutamide—AR—Integrated Breast Cancer Pathway—EGFR—asthma	2.29e-05	0.00162	CbGpPWpGaD
Bicalutamide—AR—Generic Transcription Pathway—SMAD3—asthma	2.27e-05	0.00161	CbGpPWpGaD
Bicalutamide—AR—Generic Transcription Pathway—NR3C1—asthma	2.18e-05	0.00155	CbGpPWpGaD
Bicalutamide—CYP2D6—Biological oxidations—GSTP1—asthma	2.16e-05	0.00153	CbGpPWpGaD
Bicalutamide—CYP2C19—Biological oxidations—GSTM1—asthma	2.16e-05	0.00153	CbGpPWpGaD
Bicalutamide—CYP3A4—Biological oxidations—ALDH2—asthma	2.14e-05	0.00152	CbGpPWpGaD
Bicalutamide—CYP2C9—Biological oxidations—GSTP1—asthma	2.14e-05	0.00152	CbGpPWpGaD
Bicalutamide—CYP2D6—Metapathway biotransformation—GSTP1—asthma	2.13e-05	0.00151	CbGpPWpGaD
Bicalutamide—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—asthma	2.13e-05	0.00151	CbGpPWpGaD
Bicalutamide—CYP2C19—Metapathway biotransformation—GSTM1—asthma	2.13e-05	0.00151	CbGpPWpGaD
Bicalutamide—AR—SIDS Susceptibility Pathways—TNF—asthma	2.13e-05	0.00151	CbGpPWpGaD
Bicalutamide—CYP2C9—Metapathway biotransformation—GSTP1—asthma	2.11e-05	0.0015	CbGpPWpGaD
Bicalutamide—AR—Integrated Pancreatic Cancer Pathway—VEGFA—asthma	2.11e-05	0.00149	CbGpPWpGaD
Bicalutamide—CYP3A4—Biological oxidations—GSTT1—asthma	2.04e-05	0.00144	CbGpPWpGaD
Bicalutamide—CYP2D6—Biological oxidations—GSTM1—asthma	1.98e-05	0.00141	CbGpPWpGaD
Bicalutamide—CYP2C9—Biological oxidations—GSTM1—asthma	1.97e-05	0.00139	CbGpPWpGaD
Bicalutamide—CYP2D6—Metapathway biotransformation—GSTM1—asthma	1.96e-05	0.00139	CbGpPWpGaD
Bicalutamide—AR—Gene Expression—CARM1—asthma	1.96e-05	0.00139	CbGpPWpGaD
Bicalutamide—CYP2C9—Metapathway biotransformation—GSTM1—asthma	1.94e-05	0.00137	CbGpPWpGaD
Bicalutamide—AR—Integrated Pancreatic Cancer Pathway—TGFB1—asthma	1.94e-05	0.00137	CbGpPWpGaD
Bicalutamide—AR—Integrated Pancreatic Cancer Pathway—EGFR—asthma	1.9e-05	0.00134	CbGpPWpGaD
Bicalutamide—AR—Integrated Pancreatic Cancer Pathway—TNF—asthma	1.81e-05	0.00128	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism of lipids and lipoproteins—ALOX5AP—asthma	1.76e-05	0.00125	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism of lipids and lipoproteins—ALOX15—asthma	1.76e-05	0.00125	CbGpPWpGaD
Bicalutamide—CYP3A4—Phase 1 - Functionalization of compounds—POMC—asthma	1.73e-05	0.00122	CbGpPWpGaD
Bicalutamide—AR—SIDS Susceptibility Pathways—IL6—asthma	1.72e-05	0.00122	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism of lipids and lipoproteins—CHAT—asthma	1.68e-05	0.00119	CbGpPWpGaD
Bicalutamide—AR—Gene Expression—DNMT1—asthma	1.64e-05	0.00116	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism of lipids and lipoproteins—ALOX5AP—asthma	1.6e-05	0.00114	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism of lipids and lipoproteins—ALOX15—asthma	1.6e-05	0.00114	CbGpPWpGaD
Bicalutamide—AR—Gene Expression—PARP1—asthma	1.55e-05	0.0011	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism of lipids and lipoproteins—CHAT—asthma	1.53e-05	0.00108	CbGpPWpGaD
Bicalutamide—CYP2C19—Biological oxidations—POMC—asthma	1.52e-05	0.00108	CbGpPWpGaD
Bicalutamide—AR—Generic Transcription Pathway—SERPINE1—asthma	1.52e-05	0.00108	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism of lipids and lipoproteins—ALOX5—asthma	1.49e-05	0.00106	CbGpPWpGaD
Bicalutamide—AR—Gene Expression—ESR2—asthma	1.47e-05	0.00104	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—LTC4S—asthma	1.44e-05	0.00102	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism of lipids and lipoproteins—CARM1—asthma	1.43e-05	0.00101	CbGpPWpGaD
Bicalutamide—CYP3A4—Biological oxidations—GSTP1—asthma	1.41e-05	0.001	CbGpPWpGaD
Bicalutamide—CYP2D6—Biological oxidations—POMC—asthma	1.4e-05	0.000993	CbGpPWpGaD
Bicalutamide—CYP3A4—Metapathway biotransformation—GSTP1—asthma	1.39e-05	0.000986	CbGpPWpGaD
Bicalutamide—CYP2C9—Biological oxidations—POMC—asthma	1.39e-05	0.000985	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism of lipids and lipoproteins—ALOX5—asthma	1.36e-05	0.000965	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—LTC4S—asthma	1.32e-05	0.000937	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—LTC4S—asthma	1.31e-05	0.000929	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism of lipids and lipoproteins—CARM1—asthma	1.3e-05	0.000921	CbGpPWpGaD
Bicalutamide—CYP3A4—Biological oxidations—GSTM1—asthma	1.3e-05	0.000919	CbGpPWpGaD
Bicalutamide—CYP3A4—Metapathway biotransformation—GSTM1—asthma	1.28e-05	0.000906	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—LTA4H—asthma	1.25e-05	0.000883	CbGpPWpGaD
Bicalutamide—AR—Gene Expression—VDR—asthma	1.17e-05	0.000827	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—LTA4H—asthma	1.15e-05	0.000812	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—LTA4H—asthma	1.14e-05	0.000805	CbGpPWpGaD
Bicalutamide—AR—Gene Expression—SMAD3—asthma	1.09e-05	0.000775	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—ARG1—asthma	1.09e-05	0.000772	CbGpPWpGaD
Bicalutamide—AR—Gene Expression—NR3C1—asthma	1.05e-05	0.000745	CbGpPWpGaD
Bicalutamide—AR—Gene Expression—PPP2CA—asthma	1.05e-05	0.000741	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—ARG1—asthma	1e-05	0.00071	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—ARG1—asthma	9.94e-06	0.000704	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—ALDH7A1—asthma	9.86e-06	0.000698	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—ARG2—asthma	9.45e-06	0.000669	CbGpPWpGaD
Bicalutamide—CYP3A4—Biological oxidations—POMC—asthma	9.17e-06	0.000649	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—ALDH7A1—asthma	9.07e-06	0.000642	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—ALDH7A1—asthma	8.99e-06	0.000637	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—ARG2—asthma	8.69e-06	0.000616	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—LTC4S—asthma	8.65e-06	0.000613	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—ARG2—asthma	8.62e-06	0.00061	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism of lipids and lipoproteins—PLA2G4A—asthma	8.28e-06	0.000587	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—ALOX15—asthma	7.83e-06	0.000555	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—ALOX5AP—asthma	7.83e-06	0.000555	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G4A—asthma	7.55e-06	0.000535	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—LTA4H—asthma	7.5e-06	0.000531	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—CHAT—asthma	7.47e-06	0.000529	CbGpPWpGaD
Bicalutamide—AR—Gene Expression—SERPINE1—asthma	7.34e-06	0.00052	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—ALOX5AP—asthma	7.2e-06	0.00051	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—ALOX15—asthma	7.2e-06	0.00051	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—ALOX5AP—asthma	7.14e-06	0.000506	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—ALOX15—asthma	7.14e-06	0.000506	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—CHAT—asthma	6.87e-06	0.000487	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—CHAT—asthma	6.81e-06	0.000482	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—ALOX5—asthma	6.66e-06	0.000472	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—ARG1—asthma	6.55e-06	0.000464	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—CARM1—asthma	6.35e-06	0.00045	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—DCN—asthma	6.26e-06	0.000443	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—ALOX5—asthma	6.12e-06	0.000434	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—ALDH2—asthma	6.09e-06	0.000431	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—ALOX5—asthma	6.07e-06	0.00043	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—ALDH7A1—asthma	5.93e-06	0.00042	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism of lipids and lipoproteins—POMC—asthma	5.86e-06	0.000415	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—CARM1—asthma	5.84e-06	0.000414	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—GSTT1—asthma	5.79e-06	0.00041	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—CARM1—asthma	5.79e-06	0.00041	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—DCN—asthma	5.76e-06	0.000408	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—DCN—asthma	5.71e-06	0.000404	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—ARG2—asthma	5.68e-06	0.000402	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—ALDH2—asthma	5.6e-06	0.000397	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—ALDH2—asthma	5.55e-06	0.000393	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism of lipids and lipoproteins—POMC—asthma	5.34e-06	0.000378	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism of lipids and lipoproteins—ALB—asthma	5.34e-06	0.000378	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—GSTT1—asthma	5.33e-06	0.000377	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—GSTT1—asthma	5.28e-06	0.000374	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism of lipids and lipoproteins—ALB—asthma	4.87e-06	0.000345	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—NQO1—asthma	4.81e-06	0.000341	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—ADCY2—asthma	4.71e-06	0.000334	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—ALOX5AP—asthma	4.71e-06	0.000333	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—ALOX15—asthma	4.71e-06	0.000333	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—asthma	4.67e-06	0.000331	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—CHAT—asthma	4.49e-06	0.000318	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—NQO1—asthma	4.43e-06	0.000314	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—NQO1—asthma	4.39e-06	0.000311	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—ADCY2—asthma	4.33e-06	0.000307	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—ADCY2—asthma	4.3e-06	0.000304	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—asthma	4.26e-06	0.000302	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—asthma	4.07e-06	0.000288	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—GSTP1—asthma	4.01e-06	0.000284	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—ALOX5—asthma	4e-06	0.000284	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—HMOX1—asthma	3.96e-06	0.00028	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—ITPR1—asthma	3.95e-06	0.00028	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—CAT—asthma	3.91e-06	0.000277	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—CARM1—asthma	3.82e-06	0.000271	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—DCN—asthma	3.76e-06	0.000267	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—asthma	3.71e-06	0.000263	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—GSTP1—asthma	3.69e-06	0.000262	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—PLA2G4A—asthma	3.69e-06	0.000261	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—GSTM1—asthma	3.69e-06	0.000261	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—ALDH2—asthma	3.66e-06	0.000259	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—GSTP1—asthma	3.66e-06	0.000259	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—HMOX1—asthma	3.64e-06	0.000258	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—ITPR1—asthma	3.63e-06	0.000257	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—HMOX1—asthma	3.61e-06	0.000256	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—ITPR1—asthma	3.6e-06	0.000255	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—CAT—asthma	3.59e-06	0.000254	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—CAT—asthma	3.56e-06	0.000252	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—GSTT1—asthma	3.48e-06	0.000247	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—PPP2CA—asthma	3.4e-06	0.000241	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—PLA2G4A—asthma	3.39e-06	0.00024	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—GSTM1—asthma	3.39e-06	0.00024	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—PLA2G4A—asthma	3.36e-06	0.000238	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—GSTM1—asthma	3.36e-06	0.000238	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—PPP2CA—asthma	3.13e-06	0.000221	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—PPP2CA—asthma	3.1e-06	0.000219	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—NQO1—asthma	2.89e-06	0.000205	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—ADCY2—asthma	2.83e-06	0.000201	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—POMC—asthma	2.61e-06	0.000185	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—GSTP1—asthma	2.41e-06	0.000171	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—POMC—asthma	2.4e-06	0.00017	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—HMOX1—asthma	2.38e-06	0.000169	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—POMC—asthma	2.38e-06	0.000168	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—ALB—asthma	2.38e-06	0.000168	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—ITPR1—asthma	2.38e-06	0.000168	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—CAT—asthma	2.35e-06	0.000166	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—NOS3—asthma	2.27e-06	0.000161	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—GSTM1—asthma	2.22e-06	0.000157	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—PLA2G4A—asthma	2.22e-06	0.000157	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—ALB—asthma	2.19e-06	0.000155	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—ALB—asthma	2.17e-06	0.000154	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—NOS3—asthma	2.09e-06	0.000148	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—PTGS2—asthma	2.08e-06	0.000147	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—NOS3—asthma	2.07e-06	0.000147	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—PPP2CA—asthma	2.04e-06	0.000145	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—PTGS2—asthma	1.91e-06	0.000135	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—PTGS2—asthma	1.9e-06	0.000134	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—PTEN—asthma	1.81e-06	0.000128	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—PTEN—asthma	1.67e-06	0.000118	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—PTEN—asthma	1.65e-06	0.000117	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—POMC—asthma	1.57e-06	0.000111	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—ALB—asthma	1.43e-06	0.000101	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—NOS3—asthma	1.37e-06	9.69e-05	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—PTGS2—asthma	1.25e-06	8.86e-05	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—PTEN—asthma	1.09e-06	7.73e-05	CbGpPWpGaD
